US Patent 8143380 Therapeutic peptides
Patent 8143380 was granted and assigned to Amgen on March, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+263 characters)
Article
Patent abstract
The invention relates to compounds that exhibit improved bioefficacy in multidose administration. More specifically, the invention relates to polypeptides or peptides modified to include an antibody Fc region and one or more water soluble polymers.
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Karen C. Sitney0
Kenneth W. Walker0
Olaf B. Kinstler0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08143380 Therapeutic peptides US Patent 8143380 Therapeutic peptides
Infobox
Patent Number
081433800
Patent Number
81433800
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081433800
Date of Patent
March 27, 2012
0Patent Application Number
116314610
Date Filed
July 8, 2005
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08143380 Therapeutic peptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08143380
Date of patent
March 27, 2012
Patent application number
11631461
Date Filed
July 8, 2005
Patent primary examiner
Find more entities like US Patent 8143380 Therapeutic peptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
